West Pharmaceutical Services Inc
NYSE:WST
Income Statement
Earnings Waterfall
West Pharmaceutical Services Inc
Revenue
|
2.9B
USD
|
Cost of Revenue
|
-1.8B
USD
|
Gross Profit
|
1.1B
USD
|
Operating Expenses
|
-426.5m
USD
|
Operating Income
|
661.6m
USD
|
Other Expenses
|
-92.9m
USD
|
Net Income
|
568.7m
USD
|
Income Statement
West Pharmaceutical Services Inc
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1 376
N/A
|
1 400
+2%
|
1 414
+1%
|
1 421
+1%
|
1 411
-1%
|
1 401
-1%
|
1 390
-1%
|
1 400
+1%
|
1 426
+2%
|
1 454
+2%
|
1 487
+2%
|
1 509
+2%
|
1 535
+2%
|
1 544
+1%
|
1 566
+1%
|
1 599
+2%
|
1 627
+2%
|
1 677
+3%
|
1 711
+2%
|
1 717
+0%
|
1 745
+2%
|
1 767
+1%
|
1 792
+1%
|
1 840
+3%
|
1 888
+3%
|
1 945
+3%
|
2 037
+5%
|
2 147
+5%
|
2 326
+8%
|
2 523
+8%
|
2 681
+6%
|
2 832
+6%
|
2 881
+2%
|
2 929
+2%
|
2 909
-1%
|
2 887
-1%
|
2 884
0%
|
2 866
-1%
|
2 927
+2%
|
2 950
+1%
|
2 929
-1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(946)
|
(960)
|
(970)
|
(974)
|
(959)
|
(954)
|
(944)
|
(944)
|
(957)
|
(970)
|
(989)
|
(1 008)
|
(1 023)
|
(1 041)
|
(1 058)
|
(1 087)
|
(1 114)
|
(1 147)
|
(1 170)
|
(1 172)
|
(1 187)
|
(1 194)
|
(1 206)
|
(1 234)
|
(1 262)
|
(1 282)
|
(1 327)
|
(1 379)
|
(1 453)
|
(1 530)
|
(1 595)
|
(1 654)
|
(1 691)
|
(1 732)
|
(1 732)
|
(1 751)
|
(1 761)
|
(1 773)
|
(1 813)
|
(1 821)
|
(1 841)
|
|
Gross Profit |
429
N/A
|
440
+3%
|
445
+1%
|
448
+1%
|
451
+1%
|
448
-1%
|
446
0%
|
456
+2%
|
469
+3%
|
485
+3%
|
497
+3%
|
501
+1%
|
512
+2%
|
504
-2%
|
508
+1%
|
513
+1%
|
513
+0%
|
530
+3%
|
541
+2%
|
545
+1%
|
558
+2%
|
574
+3%
|
586
+2%
|
606
+3%
|
626
+3%
|
663
+6%
|
710
+7%
|
768
+8%
|
873
+14%
|
993
+14%
|
1 086
+9%
|
1 178
+8%
|
1 190
+1%
|
1 197
+1%
|
1 177
-2%
|
1 136
-3%
|
1 123
-1%
|
1 093
-3%
|
1 113
+2%
|
1 129
+1%
|
1 088
-4%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(271)
|
(269)
|
(270)
|
(267)
|
(263)
|
(275)
|
(318)
|
(327)
|
(333)
|
(328)
|
(283)
|
(275)
|
(280)
|
(278)
|
(272)
|
(273)
|
(278)
|
(286)
|
(297)
|
(295)
|
(293)
|
(289)
|
(294)
|
(308)
|
(312)
|
(323)
|
(334)
|
(350)
|
(363)
|
(381)
|
(398)
|
(421)
|
(421)
|
(412)
|
(390)
|
(381)
|
(390)
|
(399)
|
(422)
|
(424)
|
(427)
|
|
Selling, General & Administrative |
(232)
|
(230)
|
(230)
|
(229)
|
(228)
|
(242)
|
(240)
|
(244)
|
(247)
|
(238)
|
(241)
|
(240)
|
(243)
|
(241)
|
(245)
|
(243)
|
(249)
|
(259)
|
(262)
|
(263)
|
(263)
|
(264)
|
(263)
|
(273)
|
(276)
|
(283)
|
(295)
|
(302)
|
(310)
|
(325)
|
(341)
|
(362)
|
(365)
|
(354)
|
(328)
|
(317)
|
(320)
|
(326)
|
(349)
|
(353)
|
(354)
|
|
Research & Development |
(39)
|
(39)
|
(39)
|
(37)
|
(35)
|
(33)
|
(32)
|
(34)
|
(36)
|
(37)
|
(37)
|
(37)
|
(38)
|
(39)
|
(39)
|
(39)
|
(38)
|
(39)
|
(40)
|
(40)
|
(41)
|
(39)
|
(39)
|
(39)
|
(40)
|
(41)
|
(44)
|
(47)
|
(48)
|
(51)
|
(52)
|
(53)
|
(55)
|
(56)
|
(56)
|
(59)
|
(61)
|
(63)
|
(66)
|
(68)
|
(69)
|
|
Other Operating Expenses |
0
|
0
|
(1)
|
(1)
|
(1)
|
(0)
|
(46)
|
(49)
|
(51)
|
(53)
|
(5)
|
1
|
1
|
2
|
12
|
9
|
10
|
12
|
5
|
8
|
11
|
14
|
8
|
4
|
4
|
2
|
5
|
(1)
|
(4)
|
(4)
|
(5)
|
(6)
|
(1)
|
(2)
|
(6)
|
(6)
|
(10)
|
(10)
|
(7)
|
(2)
|
(4)
|
|
Operating Income |
159
N/A
|
171
+8%
|
175
+2%
|
181
+4%
|
188
+4%
|
172
-8%
|
128
-26%
|
129
+0%
|
136
+6%
|
157
+15%
|
214
+36%
|
226
+6%
|
232
+3%
|
226
-3%
|
236
+5%
|
240
+2%
|
235
-2%
|
244
+4%
|
243
0%
|
251
+3%
|
265
+6%
|
285
+7%
|
292
+2%
|
298
+2%
|
314
+6%
|
340
+8%
|
376
+10%
|
418
+11%
|
510
+22%
|
612
+20%
|
689
+13%
|
757
+10%
|
769
+2%
|
785
+2%
|
786
+0%
|
755
-4%
|
733
-3%
|
694
-5%
|
692
0%
|
705
+2%
|
662
-6%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(15)
|
(16)
|
(14)
|
(12)
|
(11)
|
(9)
|
(13)
|
(13)
|
(11)
|
(10)
|
(9)
|
(7)
|
(7)
|
(7)
|
(6)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(0)
|
0
|
2
|
0
|
(5)
|
(9)
|
(8)
|
(7)
|
(6)
|
(5)
|
(6)
|
(3)
|
3
|
5
|
6
|
10
|
8
|
11
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(26)
|
(24)
|
(26)
|
(29)
|
(4)
|
(16)
|
(14)
|
(11)
|
(14)
|
(6)
|
(8)
|
(10)
|
(8)
|
(7)
|
(7)
|
(6)
|
(5)
|
(10)
|
(13)
|
(12)
|
(14)
|
(9)
|
(4)
|
(8)
|
(7)
|
(5)
|
(54)
|
(79)
|
(88)
|
(92)
|
(46)
|
(15)
|
(8)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
5
|
7
|
6
|
5
|
1
|
(0)
|
(1)
|
(1)
|
0
|
1
|
3
|
4
|
5
|
6
|
5
|
4
|
3
|
1
|
0
|
0
|
4
|
(1)
|
4
|
|
Pre-Tax Income |
144
N/A
|
155
+8%
|
161
+4%
|
169
+5%
|
177
+5%
|
163
-8%
|
115
-29%
|
116
+1%
|
100
-14%
|
123
+23%
|
179
+45%
|
190
+6%
|
222
+17%
|
203
-8%
|
216
+7%
|
222
+3%
|
217
-3%
|
236
+9%
|
234
-1%
|
241
+3%
|
257
+7%
|
276
+8%
|
280
+1%
|
292
+4%
|
308
+6%
|
331
+7%
|
364
+10%
|
401
+10%
|
490
+22%
|
599
+22%
|
682
+14%
|
749
+10%
|
762
+2%
|
778
+2%
|
733
-6%
|
680
-7%
|
650
-4%
|
608
-7%
|
659
+8%
|
698
+6%
|
668
-4%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(41)
|
(45)
|
(46)
|
(47)
|
(50)
|
(45)
|
(27)
|
(26)
|
(21)
|
(29)
|
(50)
|
(54)
|
(50)
|
(36)
|
(35)
|
1
|
(9)
|
(12)
|
(6)
|
(44)
|
(48)
|
(57)
|
(60)
|
(59)
|
(58)
|
(58)
|
(69)
|
(73)
|
(86)
|
(104)
|
(95)
|
(109)
|
(101)
|
(112)
|
(117)
|
(120)
|
(116)
|
(107)
|
(119)
|
(122)
|
(115)
|
|
Income from Continuing Operations |
102
|
110
|
115
|
122
|
128
|
118
|
88
|
90
|
79
|
95
|
130
|
135
|
172
|
167
|
181
|
223
|
208
|
224
|
228
|
197
|
209
|
219
|
220
|
233
|
251
|
272
|
295
|
329
|
404
|
495
|
587
|
640
|
661
|
666
|
616
|
560
|
534
|
501
|
539
|
576
|
552
|
|
Equity Earnings Affiliates |
5
|
5
|
5
|
5
|
5
|
5
|
5
|
6
|
6
|
7
|
8
|
8
|
11
|
9
|
9
|
9
|
8
|
9
|
9
|
8
|
7
|
7
|
7
|
9
|
10
|
13
|
17
|
17
|
20
|
23
|
24
|
20
|
22
|
19
|
18
|
21
|
19
|
19
|
18
|
18
|
16
|
|
Net Income (Common) |
108
N/A
|
115
+7%
|
119
+4%
|
127
+7%
|
133
+5%
|
123
-7%
|
94
-24%
|
96
+2%
|
85
-11%
|
102
+20%
|
138
+35%
|
144
+4%
|
182
+27%
|
176
-3%
|
190
+8%
|
151
-21%
|
133
-11%
|
151
+13%
|
155
+3%
|
207
+34%
|
219
+6%
|
229
+5%
|
230
+0%
|
242
+5%
|
261
+8%
|
286
+10%
|
312
+9%
|
346
+11%
|
423
+22%
|
519
+23%
|
613
+18%
|
662
+8%
|
684
+3%
|
686
+0%
|
631
-8%
|
586
-7%
|
552
-6%
|
519
-6%
|
559
+8%
|
593
+6%
|
569
-4%
|
|
EPS (Diluted) |
1.48
N/A
|
1.6
+8%
|
1.65
+3%
|
1.75
+6%
|
1.83
+5%
|
1.69
-8%
|
1.28
-24%
|
1.3
+2%
|
1.15
-12%
|
1.37
+19%
|
1.85
+35%
|
1.91
+3%
|
2.43
+27%
|
2.34
-4%
|
2.51
+7%
|
1.98
-21%
|
1.76
-11%
|
2
+14%
|
2.04
+2%
|
2.74
+34%
|
2.9
+6%
|
3.04
+5%
|
3.04
N/A
|
3.21
+6%
|
3.45
+7%
|
3.78
+10%
|
4.12
+9%
|
4.57
+11%
|
5.58
+22%
|
6.85
+23%
|
8.05
+18%
|
8.66
+8%
|
9
+4%
|
9.04
+0%
|
8.32
-8%
|
7.72
-7%
|
7.31
-5%
|
6.88
-6%
|
7.42
+8%
|
7.88
+6%
|
7.65
-3%
|